Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

K-Methylation

Financiado

Cerrado

The Role of SETD6 Methyltransferase in the Modulation of Oncogenic Processes

My overarching goal is to investigate the importance of protein post-translational modification (PTM) networks in cancer. The signaling system defined by the PTM lysine methylation has recently emerged as a potential key regulator... ver más

31/08/2017

BGU

100K€

Presupuesto del proyecto: 100K€

Líder del proyecto

BENGURION UNIVERSITY OF THE NEGEV No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2017-08-31 No tenemos la información de la convocatoria

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

BGU

0.00€ | Lider

Proyectos interesantes

TARGETSET

Medical Technol...

Data Science

150K€ Cerrado

AcetyLys

Medical Technol...

Data Science

1M€ Cerrado

SET-NET

Medical Technol...

Data Science

2M€ Cerrado

ChemProt-HLMS

Medical Technol...

Data Science

222K€ Cerrado

RTI2018-095582-B-I00

Medical Technol...

Data Science

387K€ Cerrado

DNAmethAML

Medical Technol...

Data Science

200K€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Líder del proyecto

BENGURION UNIVERSITY OF THE NEGEV No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 100K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto My overarching goal is to investigate the importance of protein post-translational modification (PTM) networks in cancer. The signaling system defined by the PTM lysine methylation has recently emerged as a potential key regulator of cancer pathways. However, the mechanisms by which protein lysine methyltransferase (PKMT) enzymes contribute to cancer are poorly understood. I believe that characterizing novel PKMTs involved in the post-translational control of cellular proteins in cancer-relevant signaling networks can provide novel insights into the basic mechanisms of cellular transformation and identify new therapeutic targets for cancer treatment. SETD6 is a PKMT whose expression is dramatically down-regulated in a wide range of human cancers. During my postdoctoral work, we identified SETD6 as a key regulator of proliferation processes by modulating the NFKB signaling pathway and deciphered the molecular mechanism for this regulation. However, knowledge of the overall mode of action of SETD6 in cancer cells and of additional endogenous substrates of this enzyme is still obscure. The working hypothesis is that SETD6 methylation of key cellular substrates modulates cancer pathology. In this research I plan to utilize cellular, biochemical, genomic and a novel proteomic experimental platform I developed to elucidate the role of SETD6 in oncogenic processes and its involvement in the modulation of cellular signaling pathways linked to cancer; to characterize new methylation events catalyzed by SETD6; to understand how these marks are generated and under which specific physiological conditions; to elucidate how these marks are sensed by other cellular factors; and to decipher the molecular mechanisms that transduce these signals. I believe that this work will provide significant insight into the role of SETD6 in the modulation of oncogenic signaling processes with a long term plan to translate this knowledge into therapeutic applications in the future.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores